Risk of Recurrent Noninfectious Uveitis After Coronavirus Disease 2019 Vaccination in the United States.

Anika Kumar, D Claire Miller, Yuwei Sun, Benjamin F Arnold, Nisha R Acharya

Abstract read

In one paragraph

Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Long COVID and the development of new-onset uveitis: a large database study.Journal of ophthalmic inflammation and infection · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anika KumarF.I. Proctor Foundation, University of California, San Francisco, California.

D Claire MillerF.I. Proctor Foundation, University of California, San Francisco, California.

Yuwei SunF.I. Proctor Foundation, University of California, San Francisco, California.

Benjamin F ArnoldF.I. Proctor Foundation, University of California, San Francisco, California.

Nisha R AcharyaF.I. Proctor Foundation, University of California, San Francisco, California.

Funding

The Impact of the Herpes Zoster Vaccine on Herpes Zoster OphthalmicusR01EY028739 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NISHA ACHARYA · 2018 to 2026

$4.5M

NEI NIH HHS R01 EY028739

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 vaccinationIncidenceNoninfectious uveitisRecurrence

Identifiers

PMID38827031

DOI10.1016/j.xops.2024.100474

PMCPMC11141252

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.